Revisiting monomeric HIV-1 protease - Characterization and redesign for improved properties

被引:49
作者
Louis, JM
Ishima, R
Nesheiwat, I
Pannell, LK
Lynch, SM
Torchia, DA
Gronenborn, AM
机构
[1] NIDCR, Struct Mol Biol Unit, NIH, Bethesda, MD 20892 USA
[2] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA
[3] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M209726200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interactions between the C-terminal interface residues (96-99) of the mature HIV-1 protease were shown to be essential for dimerization, whereas the N-terminal residues (1-4) and Arg(87) contribute to dimer stability (Ishima, R., Ghirlando, R., Tozser, J., Gronenborn, A. M., Torchia, D. A., and Louis, J. M. (2001) J. Biol. Chem. 276, 49110-49116). Here we show that the intramonomer interaction between the side chains of Asp(29) and Arg(87) influences dimerization significantly more than the intermonomer interaction between Asp29 and Arg8'. Several mutants, including T26A, destablize the dimer, exhibit a monomer fold, and are prone to aggregation. To alleviate this undesirable property, we designed proteins in which the N- and C-terminal regions can be linked intramolecularly by disulfide bonds. In particular, cysteine residues were introduced at positions 2 and 97 or 98. A procedure for the efficient preparation of intrachain-linked polypeptides is presented, and it is demonstrated that the Q2C/L97C variant exhibits a native-like single subunit fold. It is anticipated that monomeric proteases of this kind will aid in the discovery of novel inhibitors aimed at binding to the monomer at the dimerization interface. This extends the target area of current inhibitors, all of which bind across the active site formed by both subunits in the active dimer.
引用
收藏
页码:6085 / 6092
页数:8
相关论文
共 25 条
[1]   Intravirion display of a peptide corresponding to the dimer interface structure of protease attenuates HIV-1 replication [J].
Cartas, M ;
Singh, SP ;
Serio, D ;
Rizvi, TA ;
Kalyanaraman, VS ;
Goldsmith, CS ;
Zaki, SR ;
Weber, IT ;
Srinivasan, A .
DNA AND CELL BIOLOGY, 2001, 20 (12) :797-805
[2]   Resistance to HIV protease inhibitors [J].
Condra, JH .
HAEMOPHILIA, 1998, 4 (04) :610-615
[3]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[4]   Structural mechanisms of HIV drug resistance [J].
Erickson, JW ;
Burt, SK .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :545-571
[5]   A COMMON-SENSE APPROACH TO PEAK PICKING IN 2-DIMENSIONAL, 3-DIMENSIONAL, AND 4-DIMENSIONAL SPECTRA USING AUTOMATIC COMPUTER-ANALYSIS OF CONTOUR DIAGRAMS [J].
GARRETT, DS ;
POWERS, R ;
GRONENBORN, AM ;
CLORE, GM .
JOURNAL OF MAGNETIC RESONANCE, 1991, 95 (01) :214-220
[6]   USE OF PROTEIN UNFOLDING STUDIES TO DETERMINE THE CONFORMATIONAL AND DIMERIC STABILITIES OF HIV-1 AND SIV PROTEASES [J].
GRANT, SK ;
DECKMAN, IC ;
CULP, JS ;
MINNICH, MD ;
BROOKS, IS ;
HENSLEY, P ;
DEBOUCK, C ;
MEEK, TD .
BIOCHEMISTRY, 1992, 31 (39) :9491-9501
[7]   Protein folding - Molecular chaperones in the cytosol: from nascent chain to folded protein [J].
Hartl, FU ;
Hayer-Hartl, M .
SCIENCE, 2002, 295 (5561) :1852-1858
[8]   Folded monomer of HIV-1 protease [J].
Ishima, R ;
Ghirlando, R ;
Tözsér, J ;
Gronenborn, AM ;
Torchia, DA ;
Louis, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :49110-49116
[9]  
KUIKEN C, 2001, HIV SEQUENCE COMPEND
[10]   KINETICS AND MECHANISM OF AUTOPROCESSING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE FROM AN ANALOG OF THE GAG-POL POLYPROTEIN [J].
LOUIS, JM ;
NASHED, NT ;
PARRIS, KD ;
KIMMEL, AR ;
JERINA, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (17) :7970-7974